Epitope focus, clonal composition and Th1 phenotype of the human CD4 response to the secretory mycobacterial antigen Ag85

被引:27
作者
Valle, MT
Megiovanni, AM
Merlo, A
Pira, GL
Bottone, L
Angelini, G
Bracci, L
Lozzi, L
Huygen, K
Manca, F
机构
[1] Adv Biotechnol Ctr, Unit Retroviral Immunol, I-16132 Genoa, Italy
[2] San Martino Hosp, Immunol Lab, Genoa, Italy
[3] Univ Siena, Dept Mol Biol, I-53100 Siena, Italy
[4] Inst Pasteur, Brussels, Belgium
关键词
mycobacteria; CD4; T cells; Ag85; immunodominant epitope; TCRBV;
D O I
10.1046/j.1365-2249.2001.01450.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Lymphoproliferation of healthy donors was tested against mycobacterial antigens (PPD, Ag85, Ag85 peptides). All PPD responders recognized the secretory antigen Ag85 and the peptide specificity for Ag85B was defined. Peptide 91-108 was recognized by 85% of donors. In addition, all CD4 T cell lines generated from 12 donors against PPD or Ag85 responded to 91-108. When this peptide was used to generate T cell lines, the cells responded also to tuberculins from atypical mycobacterial species. Thus the cross-reactive peptide behaved as quasi-universal. The analysis of TCR-BV gene usage by cell lines showed that most Ag85-specific T cells correspond to 91-108-specific clonotypes. Intracytoplasmic staining of cell lines after phorbol myristate acetate stimulation resulted in dominance of interferon-gamma (IFN-gamma)-IL-4 double-positive cells, whereas antigen stimulation resulted in production of IFN-gamma only. The data show that peptide 91-108 is the major focus of the CD4 response to mycobacterial antigens in peripheral blood mononuclear cells and in T cell lines from PPD responders.
引用
收藏
页码:226 / 232
页数:7
相关论文
共 32 条
[2]   HUMAN MYCOBACTERIUM-TUBERCULOSIS-REACTIVE CD4+ T-CELL CLONES - HETEROGENEITY IN ANTIGEN RECOGNITION, CYTOKINE PRODUCTION, AND CYTOTOXICITY FOR MONONUCLEAR PHAGOCYTES [J].
BOOM, WH ;
WALLIS, RS ;
CHERVENAK, KA .
INFECTION AND IMMUNITY, 1991, 59 (08) :2737-2743
[3]   Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence [J].
Cole, ST ;
Brosch, R ;
Parkhill, J ;
Garnier, T ;
Churcher, C ;
Harris, D ;
Gordon, SV ;
Eiglmeier, K ;
Gas, S ;
Barry, CE ;
Tekaia, F ;
Badcock, K ;
Basham, D ;
Brown, D ;
Chillingworth, T ;
Connor, R ;
Davies, R ;
Devlin, K ;
Feltwell, T ;
Gentles, S ;
Hamlin, N ;
Holroyd, S ;
Hornby, T ;
Jagels, K ;
Krogh, A ;
McLean, J ;
Moule, S ;
Murphy, L ;
Oliver, K ;
Osborne, J ;
Quail, MA ;
Rajandream, MA ;
Rogers, J ;
Rutter, S ;
Seeger, K ;
Skelton, J ;
Squares, R ;
Squares, S ;
Sulston, JE ;
Taylor, K ;
Whitehead, S ;
Barrell, BG .
NATURE, 1998, 393 (6685) :537-+
[4]   PURIFICATION, CHARACTERIZATION AND IDENTIFICATION OF A 32 KDA PROTEIN ANTIGEN OF MYCOBACTERIUM-BOVIS BCG [J].
DEBRUYN, J ;
HUYGEN, K ;
BOSMANS, R ;
FAUVILLE, M ;
LIPPENS, R ;
VANVOOREN, JP ;
FALMAGNE, P ;
WECKX, M ;
WIKER, HG ;
HARBOE, M ;
TURNEER, M .
MICROBIAL PATHOGENESIS, 1987, 2 (05) :351-366
[5]  
FINE PEM, 1989, REV INFECT DIS, V11, pS353
[6]   Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG [J].
Harboe, M ;
Oettinger, T ;
Wiker, HG ;
Rosenkrands, I ;
Andersen, P .
INFECTION AND IMMUNITY, 1996, 64 (01) :16-22
[7]   PROTECTIVE IMMUNITY AGAINST TUBERCULOSIS INDUCED BY VACCINATION WITH MAJOR EXTRACELLULAR PROTEINS OF MYCOBACTERIUM-TUBERCULOSIS [J].
HORWITZ, MA ;
LEE, BWE ;
DILLON, BJ ;
HARTH, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (05) :1530-1534
[8]   Immunogenicity and protective efficacy of a tuberculosis DNA vaccine [J].
Huygen, K ;
Content, J ;
Denis, O ;
Montgomery, DL ;
Yawman, AM ;
Deck, RR ;
DeWitt, CM ;
Orme, IM ;
Baldwin, S ;
DSouza, C ;
Drowart, A ;
Lozes, E ;
Vandenbussche, P ;
VanVooren, JP ;
Liu, MA ;
Ulmer, JB .
NATURE MEDICINE, 1996, 2 (08) :893-898
[9]   MAPPING OF TH1 HELPER T-CELL EPITOPES ON MAJOR SECRETED MYCOBACTERIAL ANTIGEN 85A IN MICE INFECTED WITH LIVE MYCOBACTERIUM-BOVIS BCG [J].
HUYGEN, K ;
LOZES, E ;
GILLES, B ;
DROWART, A ;
PALFLIET, K ;
JURION, F ;
ROLAND, I ;
ART, M ;
DUFAUX, M ;
NYABENDA, J ;
DEBRUYN, J ;
VANVOOREN, JP ;
DELEYS, R .
INFECTION AND IMMUNITY, 1994, 62 (02) :363-370
[10]  
Kamath AT, 1999, INFECT IMMUN, V67, P1702